Advertisement

Topics

Latest "New England Anti-Vivisection Society" News Stories

22:28 EST 11th December 2018 | BioPortfolio

Here are the most relevant search results for "New England Anti-Vivisection Society" found in our extensive news archives from over 250 global news sources.

More Information about New England Anti-Vivisection Society on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about New England Anti-Vivisection Society for you to read. Along with our medical data and news we also list New England Anti-Vivisection Society Clinical Trials, which are updated daily. BioPortfolio also has a large database of New England Anti-Vivisection Society Companies for you to search.

Showing "England Anti Vivisection Society" News Articles 1–25 of 7,700+

Tuesday 11th December 2018

Dr. Ariel Ostad Joins the Exclusive Haute Beauty Network.

Dr. Ariel Ostad, a Cosmetic Dermatologist of New York City has partnered with the esteemed Haute Beauty network. (PRWEB) December 11, 2018 Dr. Ariel Ostad, a Cosmetic Dermatologist of New York City has partnered with the esteemed Haute Beauty network. The Haute Beauty Network, well known for their exclusivity, and luxurious lifestyle publication is privileged to present Dr. Ostad as a leading Co...


Reliant Bank Earns Top Fundraising Honors with Donation to Leukemia and Lymphoma Society

Bank Doubles Donation from Prior Year during Costumed for a Cure Contest Reliant Bank announced a donation of more than $4,000 to the Leukemia and Lymphoma Society. In its second year participating in the Costumed for a Cure fundraiser, the bank placed first in overall funding in Tennessee and doubled their contribution amount raised in the prior year....

Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering

Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or the “Company”), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced the closing of an underwritten offering for gross proceeds of approximately $10 million, prior to deducting underwriting discounts and co...


Gut Microbiome May Affect Some Anti-Diabetes Drugs

NewsWhy do orally-administered drugs for diabetes work for some people but not others?Contributed Author: 

Prominent Doctors Aren’t Disclosing Their Industry Ties in Medical Journal Studies. And Journals Are Doing Little to Enforce Their Rules

(Pro Publica) – One is dean of Yale’s medical school. Another is the director of a cancer center in Texas. A third is the next president of the most prominent society of cancer doctors. These leading medical figures are among … Read More

Lifelong Lessons in Reliability and Safety

SOURCE: CLP Group DESCRIPTION:Derek Parkin, CLP Holdings Chief Operating Officer (COO), vividly remembers an early lesson in the importance of reliability and safety. Born into a coal mining family in the north of England, he landed his first job as a 16-year-old schoolboy cleaning the floors of the offices at a coal mine. He was sweeping the floor one day in what seemed like a mundane chore when ...

Innovation’s Phil Samples elected to AMSUS board

Gut bacteria may modify effectiveness of anti-diabetes drugs

Why do orally-administered drugs for diabetes work for some people but not others? According to researchers at Wake Forest School of Medicine, bacteria that make up the gut microbiome may be the culprit.

Indoor cooking with coal, wood tied to increased morbidity, mortality risk, ATS reports

The below Sept. 21, 2018 press release is from the American Thoracic Society. Burning wood or coal to cook food is associated with increased risk of hospitalization or dying from respiratory diseases, a

MetrioPharm AG: MetrioPharm AG Closes Financing Round of CHF 20 Million

EQS Group-News: MetrioPharm AG / Key word(s): Financing/Capital Increase 11.12.2018 / 16:46 Zurich, December 11, 2018. MetrioPharm AG, a clinical stage pharmaceutical development company, announces that it has successfully completed the current financing round D. MetrioPharm CEO Dr. Wolfgang Brysch: "We are pleased to have completed the current financing round as planned in 2018. Altoget...

Wow, this K-M survival analysis in #GoT by @RLystad is brilliant! http://blogs.biomedcentral.com/on-society/2018/12/10/mortality-and-survival-in-game-of-thrones-who-will-live-and-who-will-die/?utm_campaign=shareaholic&utm_medium=twitter&utm_source=social

Wow, this K-M survival analysis in #GoT by @RLystad is brilliant! http://blogs.biomedcentral.com/on-society/2018/12/10/mortality-and-survival-in-game-of-thrones-who-will-live-and-who-will-die/?utm_campaign=shareaholic&utm_medium=twitter&utm_source=socialnetwork … &l

Global Testosterone Replacement Therapy Market 2019-2023 | Rise in Novel Therapeutic Approaches to Boost Demand | Technavio

The global testosterone replacement therapy market is expected to decelerate at CAGR of over (2%) during the period 2019-2023, according to the latest market research report by Technavio. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181211005655/en/

Myositis and Cancer: Quantifying the Link

(MedPage Today) -- Risk highest for carriers of anti-TIF1 antibody

Anti-CD47 gel prevents cancer recurrence after surgery

Roche Collaborates With Merck On Development Of Companion Diagnostic Test

KENILWORTH (NJ) (dpa-AFX) - Roche (RHHBY) said that it reached a collaboration with Merck to develop a companion diagnostic test to identify patients eligible for anti-PD-1 therapy based on the st...

Alina Lourie, departing director of Pharmaceutical Press, on taking RPS publishing into the digital age

Alina Lourie, managing director of Pharmaceutical Press, will be stepping down from her role in December 2018 after six-and-a-half years leading the publishing division of the Royal Pharmaceutical Society.

Roche to develop companion diagnostic test to help identify patients eligible for anti-PD-1 therapy based on biomarker expression, not location, of solid tumors

- Roche collaborates with Merck to develop companion diagnostic for use with Keytruda (pembrolizumab), Merck's anti-PD-1 therapy, in advanced solid tumors with mismatch repair deficiency (dMMR) - ...

Are you stressed? Your eyes may provide a window into your mental workload

With nearly breakneck speed, the demands of work productivity in today's society seem to have increased tenfold. Enter multitasking as a way to cope with the insistence that tasks be completed almost immediately. Previous studies on workload and productivity include physical aspects, such as how much a person walks or carries, but they do not take into account a person's state of mind. Now, resear...

PharmaCyte Discusses Pancreatic Cancer Clinical Trial with Medpace’s Medical Monitor Dr. Lyon Gleich

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, released an interview with Lyon Gleich, M.D., of Medpace, a global full-service clinical contract research organization (CRO). Dr. Gleich serves as the Med...

PCI Synthesis Identifies Trends Affecting the Generic Drugs Sector in 2019

A Shift to Outsourcing, Practical Innovation, Increased Reliance on Raw Material and Faster FDA Approvals Dominate the Sector in 2019 PCI Synthesis, Inc. (www.pcisynthesis.com), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical

Consort Medical plc CSRT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryConsort Medical plc Consort Medical is a contract development and manufacturing organization CDMO with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and pointofcare POC diagnostics. It offers metered dose inhalers, dry powder devices, actuators, dose counters, disposable autoinjectors, n...

Physiomics Plc PYC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryPhysiomics plc Physiomics is a computational systems biology services company. It offers Virtual Tumour, which optimizes the dosing and scheduling of oncology drugs in preclinical trials, cardiac toxicity services through its EasyAP, a Webbased simulation and analysis tool. It also offers model based drug development services, which includes population PKPD analysis of clinical data, backtr...

Wayne Imber to Provide Free Holiday Cooking Tips this season

Individuals who would like to learn how to cook on a budget this holiday season can soon access a free resource by Wayne Imber. LOS ANGELES (PRWEB) December 11, 2018 Those who would like to prepare delectable yet budget-friendly meals for the holidays can soon access a free online resource featuring related tips from Wayne Imber, who is celebrating the anniversary of his highly successful publica...

HMP and Wound Healing Society Announce Renewed Strategic Partnership

Expanded collaboration underscores organizations’ commitment to providing exceptional education for the global wound care community MALVERN, Pa. (PRWEB) December 11, 2018 HMP, a leader in healthcare events and education and the creator and organizer of the annual Symposium on Advanced Wound Care (SAWC) Spring meeting, today announced a new five-year agreement with the Wound Healing Society (WHS...

Julie M. Lewis Named General Counsel and Corporate Secretary at Carestream Health

Julie M. Lewis has been appointed General Counsel and Corporate Secretary at Carestream Health effective immediately. She will lead the company’s worldwide legal organization and is a member of the company’s senior executive leadership team. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/201812110051...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks